UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 16,917 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 37.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 62,566 shares of the company's stock after purchasing an additional 16,917 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.15% of Phibro Animal Health worth $1,314,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Point72 Asia Singapore Pte. Ltd. acquired a new position in Phibro Animal Health during the fourth quarter worth about $29,000. Lazard Asset Management LLC increased its position in shares of Phibro Animal Health by 2,739.7% during the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after buying an additional 1,589 shares during the period. Aquatic Capital Management LLC bought a new stake in Phibro Animal Health during the fourth quarter valued at $69,000. Virtus Fund Advisers LLC acquired a new stake in Phibro Animal Health during the fourth quarter worth approximately $69,000. Finally, Quantbot Technologies LP grew its position in shares of Phibro Animal Health by 65.1% during the 4th quarter. Quantbot Technologies LP now owns 5,116 shares of the company's stock worth $107,000 after buying an additional 2,018 shares during the period. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Stock Up 0.5%

Phibro Animal Health stock traded up $0.12 during trading on Thursday, hitting $24.51. 174,465 shares of the company were exchanged, compared to its average volume of 204,247. The company has a market capitalization of $993.49 million, a P/E ratio of 51.06, a PEG ratio of 0.45 and a beta of 0.74. The business's 50 day moving average is $21.01 and its 200 day moving average is $21.90. Phibro Animal Health Co. has a 52 week low of $16.16 and a 52 week high of $26.55. The company has a current ratio of 3.20, a quick ratio of 1.37 and a debt-to-equity ratio of 2.99.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.11. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. The firm had revenue of $347.80 million during the quarter, compared to analyst estimates of $352.41 million. Analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.96%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio is currently 61.54%.

Analyst Upgrades and Downgrades

PAHC has been the subject of a number of recent research reports. Morgan Stanley boosted their price target on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a research note on Thursday, May 8th. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $20.00.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.